Medicine Information

Vioxx Personal Injury Lawsuits


Personal injury attorneys representing clients who have allegedly been harmed by the prescription drug Vioxx are congratulating themselves over a historic judgment rendered recently. On August 19, 2005, a judge awarded the family of Bob Ernst $253.4 million due to his death from the drug. Vioxx, which had been prescribed most often for arthritis pain, was withdrawn globally by its maker, Merck, after research trials showed it increased patients' chances of a heart attack. Although Merck pulled the drug off the market in September 2004, legal action against this leading pharmaceutical giant will continue and expand. Let's take a look at why Vioxx has become a litigation lightning rod.

In 1998 as Merck was running clinical trials for Vioxx, company reports to the FDA stated that there were no cardiovascular signals apparent. This meant that there were no telltale signs that the drug could cause heart problems for users. Later, however, it was revealed that an internal study conducted by Merck around the same time - Study 090 - revealed serious cardiovascular problems as compared to patients not taking Vioxx. The study was never published by Merck as the company insisted that it was not large enough to provide definitive data.

The following year the FDA gave Vioxx its approval and the drug became the second nonsteroidal anti-inflammatory medication [or COX-2 inhibitor] to hit the market. Celebrex, another problem drug, was the first.

Merck widely and thoroughly launched a marketing campaign upon the introduction of Vioxx to the marketplace. Indeed, by 2003 the drug had entered 80 nations with sales exceeding $2.5 billion. Still, there were problems looming as ongoing tests conducted by Merck hinted of potential deadly side effects.

As early as 2001, the FDA recommended label warnings be put on prescriptions warning users of potential side effects. In addition, Merck was warned by the FDA to quit misleading physicians about potential side effects.

As potential problems began to surface, they served as red flags to industry watchdogs, to the FDA, as well as to personal injury attorneys who began to gather evidence to show that Merck was negligent. Indeed, web sites and advertising campaigns - meant to inform and attract patients harmed by the drug - were launched and fairly soon the internet, radio, television, and print media were flooded with advertisements asking those suspecting harm from Vioxx to come forward.

With the September 2004 announcement that Merck was withdrawing Vioxx, personal injury litigation was well on its way to being established. By early 2005, the first cases were filed and the Ernst case became the first Vioxx lawsuit to be settled.

Wrongful death lawsuits against Vioxx's maker, Merck, are expected to increase as the result of the Ernst decision. Personal injury attorneys insist that thousands of former Vioxx users and/or their families are due compensation for Merck's neglect. It remains to be seen if juries will render judgments as large as the Ernst judgment and whether courts will uphold these amounts. Nevertheless, it is certain that Merck is in for a long battle that will reach well beyond its US base.

Matthew Keegan is The Article Writer who writes on just about any and every issue imaginable. You can preview samples from his high performing site at http://www.thearticlewriter.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Forbes

Medicine and Dentistry: Undoing an Illogical 150-Year Divide
Forbes
It's no secret that medicine and dentistry have evolved an unnatural professional separation that is helpful to no one and often causes unnecessary suffering on the part of patients. But we're in a moment—driven by our greater understanding of the ...



PharmaTimes

Mirati joins CR UK's Stratified Medicine Programme
PharmaTimes
Mirati Therapeutics has joined Cancer Research UK's Stratified Medicine Programme, bringing new investigational treatment options to eligible patients with advanced lung cancer. The partnership will make Mirati's experimental drug, sitravatinib ...



Healthcare IT News

Center for Connected Medicine polls top health systems about 2019 priorities
Healthcare IT News
The Center for Connected Medicine polled IT executives across 38 health systems for its 2019 Top of Mind survey. Cybersecurity continues to be the biggest concern across the industry, with telehealth and interoperability not far behind. Those topics ...

and more »


AAFP News (blog)

Bustling Clerkship Shows Family Medicine Is Never Boring
AAFP News (blog)
Not only was family medicine the first specialty I was ever interested in, it was my first third-year clerkship in medical school, too. Although I started medical school thinking family medicine was the specialty for me, it wasn't until my clinical ...



OncLive

Dr. Borgen on Precision Medicine in Breast Cancer
OncLive
The TAILORx trial, which was discussed at the 2018 ASCO Annual Meeting, is a perfect example of precision medicine making its way into this space, according to Borgen. Data from this trial suggested that by applying the precision medicine concept in ...



News3LV

Pulmonary Medicine
News3LV
Pulmonary Medicine. OptumCare Lung and Allergy Care. Chronic obstructive pulmonary disease, or “COPD” is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus production ...

and more »


Washington University School of Medicine in St. Louis

MRI scans shows promise in predicting dementia
Washington University School of Medicine in St. Louis
In a small study, MRI brain scans predicted with 89 percent accuracy who would go on to develop dementia within three years, according to research at Washington University School of Medicine in St. Louis and the University of California San Francisco.
Researchers Use MRI to Predict Alzheimer's DiseasePRNewswire

all 36 news articles »


Stanford Medical Center Report

Stanford Medicine magazine reports on ways digital technology is transforming health care
Stanford Medical Center Report
Four programs highlight how Stanford Medicine uses digital technology to fill in gaps in care: An emergency room physician uses tablet computers to train community health care workers in underserved areas of Haiti and India; radiologists transformed ...



Mylan recalls batches of blood pressure medicine in US
Reuters
(Reuters) - Mylan NV said on Tuesday it would recall certain batches of blood pressure medicine valsartan in the United States after they were found to contain a probable cancer-causing impurity, the latest recall amid heightened safety concerns globally.

and more »


KRVS

Medicine Ball Caravan: November 20, 2018
KRVS
We've got sound to heal you on Tuesday's MEDICINE BALL CARAVAN on KRVS (11am-noon Central Standard on 88.7FM locally or krvs.org) with recent selections from Paul McCartney, Zuider Zee, Sunflower Bean and The Record Company. Also: familiar ...


Google News

home | site map | Dr. Thad Thomas
© 2006